Used in pharmaceutical research as an intermediate in the synthesis of neuroactive compounds. Shows potential in the development of agents targeting central nervous system disorders due to its structural similarity to monoaminergic ligands. Also employed in studies related to dopamine and norepinephrine modulation. Investigated for use in treating cognitive and mood-related conditions. Serves as a building block in medicinal chemistry for creating novel analogs with improved blood-brain barrier penetration.